Table 4 Patient outcome and survival
All patients (n = 282) | Patients without visceral metastasis (n = 220) | Patients with visceral metastasis (n = 62) | |||
|---|---|---|---|---|---|
Curative treatment (n = 151) | BSC (n = 69) | Palliative treatment (n = 30) | BSC (n = 32) | ||
Overall survival (month, SD) | 9.7 ± 1.0 | 17.8 ± 1.5 | 5.5 ± 2.0 * | 6.7 ± 2.1 | 1.8 ± 0.4 ** |
Specific survival (month, SD) | 11.5 ± 0.7 | 23.2 ± 5.3 | 6.1 ± 2.5 * | 6.7 ± 2.1 | 1.8 ± 0.4 ** |
Deaths | 206 (73.0%) | 113 (74.8%) | 42 (60.9%) | 24 (80.0%) | 27 (84.4%) |
Causes of death | |||||
cancer | 181 (87.9%) | 91 (80.5%) | 40 (95.2%) | 24 (100%) | 26 (96.3%) |
treatment | 5 (2.4%) | 3 (2.6%) | 1 (2.4%) | 0 | 1 (3.7%) |
other | 20 (9.7%) | 19 (16.8%) | 1 (2.4%) | 0 | 0 |